vs
奎斯特诊断（IMDX）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
奎斯特诊断的季度营收约是Arcadia Biosciences, Inc.的1.3倍（$1.1M vs $901.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -2015.4%，领先1867.1%），奎斯特诊断同比增速更快（-23.4% vs -25.8%），过去两年奎斯特诊断的营收复合增速更高（154.4% vs -4.5%）
奎斯特诊断公司是一家美国临床检验企业，跻身财富500强，业务覆盖美国本土，以及波多黎各、墨西哥、巴西等地区，同时与全球多家医院和诊所保持合作关系，是行业内颇具影响力的医疗诊断服务提供商。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
IMDX vs RKDA — 直观对比
营收规模更大
IMDX
是对方的1.3倍
$901.0K
营收增速更快
IMDX
高出2.5%
-25.8%
净利率更高
RKDA
高出1867.1%
-2015.4%
两年增速更快
IMDX
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $901.0K |
| 净利润 | $-23.0M | $-1.3M |
| 毛利率 | 42.5% | 21.4% |
| 营业利润率 | -2057.5% | -152.8% |
| 净利率 | -2015.4% | -148.3% |
| 营收同比 | -23.4% | -25.8% |
| 净利润同比 | 31.5% | 67.1% |
| 每股收益（稀释后） | $-0.75 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMDXRKDA
| Q4 25 | $1.1M | $901.0K | ||
| Q3 25 | $260.0K | $1.3M | ||
| Q2 25 | $518.0K | $1.5M | ||
| Q1 25 | $2.1M | $1.2M | ||
| Q4 24 | $1.5M | $1.2M | ||
| Q3 24 | $115.0K | $1.5M | ||
| Q2 24 | $104.0K | $1.3M | ||
| Q1 24 | $176.0K | $987.0K |
净利润IMDXRKDA
| Q4 25 | $-23.0M | $-1.3M | ||
| Q3 25 | $-10.9M | $856.0K | ||
| Q2 25 | $-9.7M | $-4.5M | ||
| Q1 25 | $-6.7M | $2.6M | ||
| Q4 24 | $-33.5M | $-4.1M | ||
| Q3 24 | $-13.5M | $-1.6M | ||
| Q2 24 | $-4.5M | $1.1M | ||
| Q1 24 | $-9.1M | $-2.4M |
毛利率IMDXRKDA
| Q4 25 | 42.5% | 21.4% | ||
| Q3 25 | 53.5% | 32.1% | ||
| Q2 25 | 67.6% | 43.4% | ||
| Q1 25 | 62.0% | 43.2% | ||
| Q4 24 | 40.0% | 31.9% | ||
| Q3 24 | 43.5% | 32.9% | ||
| Q2 24 | 48.1% | 51.5% | ||
| Q1 24 | 25.6% | 52.3% |
营业利润率IMDXRKDA
| Q4 25 | -2057.5% | -152.8% | ||
| Q3 25 | -4249.2% | -88.5% | ||
| Q2 25 | -1900.0% | -34.4% | ||
| Q1 25 | -318.0% | 44.2% | ||
| Q4 24 | -2262.9% | -187.7% | ||
| Q3 24 | -11752.2% | -114.5% | ||
| Q2 24 | -4453.8% | — | ||
| Q1 24 | -5265.3% | -160.9% |
净利率IMDXRKDA
| Q4 25 | -2015.4% | -148.3% | ||
| Q3 25 | -4174.6% | 65.7% | ||
| Q2 25 | -1880.7% | -306.4% | ||
| Q1 25 | -312.0% | 216.6% | ||
| Q4 24 | -2255.1% | -334.5% | ||
| Q3 24 | -11733.0% | -104.9% | ||
| Q2 24 | -4355.8% | 81.2% | ||
| Q1 24 | -5186.9% | -245.5% |
每股收益（稀释后）IMDXRKDA
| Q4 25 | $-0.75 | $-0.97 | ||
| Q3 25 | $-0.34 | $0.62 | ||
| Q2 25 | $-0.30 | $-3.26 | ||
| Q1 25 | $-0.26 | $1.90 | ||
| Q4 24 | $-2.19 | $-2.99 | ||
| Q3 24 | $-0.98 | $-1.18 | ||
| Q2 24 | $-0.36 | $0.78 | ||
| Q1 24 | $-1.13 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.6M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-31.5M | $4.1M |
| 总资产 | $25.8M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMDXRKDA
| Q4 25 | $11.6M | $4.6M | ||
| Q3 25 | $18.7M | $5.9M | ||
| Q2 25 | $24.3M | $4.4M | ||
| Q1 25 | $31.0M | $3.2M | ||
| Q4 24 | $8.6M | $4.2M | ||
| Q3 24 | $3.4M | $6.6M | ||
| Q2 24 | $9.3M | $8.1M | ||
| Q1 24 | $5.6M | $8.5M |
股东权益IMDXRKDA
| Q4 25 | $-31.5M | $4.1M | ||
| Q3 25 | $-9.2M | $5.4M | ||
| Q2 25 | $1.1M | $4.5M | ||
| Q1 25 | $10.2M | $8.9M | ||
| Q4 24 | $-12.3M | $6.2M | ||
| Q3 24 | $9.7M | $10.3M | ||
| Q2 24 | $22.7M | $11.7M | ||
| Q1 24 | $11.6M | $10.6M |
总资产IMDXRKDA
| Q4 25 | $25.8M | $6.5M | ||
| Q3 25 | $43.9M | $8.6M | ||
| Q2 25 | $50.5M | $7.8M | ||
| Q1 25 | $60.4M | $13.0M | ||
| Q4 24 | $35.1M | $13.5M | ||
| Q3 24 | $70.2M | $15.2M | ||
| Q2 24 | $74.7M | $17.4M | ||
| Q1 24 | $71.0M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.5M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-7.0M | — |
| 自由现金流率自由现金流/营收 | -616.7% | — |
| 资本支出强度资本支出/营收 | 129.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-25.4M | — |
8季度趋势，按日历期对齐
经营现金流IMDXRKDA
| Q4 25 | $-5.5M | $-861.0K | ||
| Q3 25 | $-4.5M | $-257.0K | ||
| Q2 25 | $-6.3M | $-2.0M | ||
| Q1 25 | $-5.9M | $-1.6M | ||
| Q4 24 | $-5.4M | $-2.2M | ||
| Q3 24 | $-5.5M | $-1.8M | ||
| Q2 24 | $-6.0M | $-2.5M | ||
| Q1 24 | $-3.8M | $-3.2M |
自由现金流IMDXRKDA
| Q4 25 | $-7.0M | — | ||
| Q3 25 | $-5.6M | — | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $-5.6M | — | ||
| Q2 24 | $-6.2M | $-2.5M | ||
| Q1 24 | $-3.9M | $-3.2M |
自由现金流率IMDXRKDA
| Q4 25 | -616.7% | — | ||
| Q3 25 | -2135.4% | — | ||
| Q2 25 | -1279.5% | — | ||
| Q1 25 | -288.4% | — | ||
| Q4 24 | -374.5% | — | ||
| Q3 24 | -4884.3% | — | ||
| Q2 24 | -5931.7% | -188.3% | ||
| Q1 24 | -2189.8% | -326.5% |
资本支出强度IMDXRKDA
| Q4 25 | 129.9% | 0.0% | ||
| Q3 25 | 403.8% | 0.0% | ||
| Q2 25 | 67.4% | 0.0% | ||
| Q1 25 | 14.4% | 0.0% | ||
| Q4 24 | 14.4% | 0.0% | ||
| Q3 24 | 75.7% | 0.0% | ||
| Q2 24 | 183.7% | 0.2% | ||
| Q1 24 | 13.6% | 1.3% |
现金转化率IMDXRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
